Dr. Uyei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 E Hamilton Ave
Ste 200
Campbell, CA 95008Phone+1 408-376-2300Fax+1 408-376-2316
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2003 - 2006
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2000 - 2003
Yale School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 375 citationsAtezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the ...Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl D. Lewis
Lancet. 2020-06-13 - 339 citationsAtezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, random...Cathy Eng, Cathy Eng, Tae Won Kim, Johanna C. Bendell, Guillem Argiles
The Lancet. Oncology. 2019-06-01 - 22 citationsA Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advance...Christopher H. Lieu, Manuel Hidalgo, Jordan Berlin, Andrew H. Ko, Andrés Cervantes
The Oncologist. 2017-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
